Verrica Pharmaceuticals Inc

Verrica Pharmaceuticals Announces Positive Results from Phase 3 Trial of TO-208 for Molluscum Treatment in Japan

WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a leading dermatology therapeutics provider, has shared promising top-line results from the Phase 3 trial of TO-208 for molluscum contagiosum (“molluscum”) …

Verrica Pharmaceuticals Announces Positive Results from Phase 3 Trial of TO-208 for Molluscum Treatment in Japan Read More


Cantaloupe

Cantaloupe, Inc. Launches Seed Analytics and Seed Intelligence, Transforming Vending Operations with Data-Driven Tools

MALVERN, PA — Cantaloupe, Inc. (NASDAQ: CTLP), a leading provider of digital payment, vending IoT and AI-driven technology solutions, has announced the release of two new premium analytics tools on …

Cantaloupe, Inc. Launches Seed Analytics and Seed Intelligence, Transforming Vending Operations with Data-Driven Tools Read More
Ecovyst

Ecovyst Inc. Unveils Rebranding of Advanced Silicas Portfolio, Emphasizing Innovation and Sustainability

MALVERN, PA — Leading supplier, developer, and partner in catalysis and other advanced material applications, Ecovyst Inc., recently announced a significant rebranding of its Advanced Silicas product portfolio. The rebranding …

Ecovyst Inc. Unveils Rebranding of Advanced Silicas Portfolio, Emphasizing Innovation and Sustainability Read More

West Pharmaceutical Services, Inc. (NYSE: WST)

West Pharmaceutical Services Expands Injectable Drug Portfolio with FDA Cleared Vial2Bag Advanced 13mm Admixture Device

EXTON, PA — In a move that strengthens its position as a global leader in innovative solutions for injectable drug administration systems, West Pharmaceutical Services, Inc. (NYSE: WST) recently announced …

West Pharmaceutical Services Expands Injectable Drug Portfolio with FDA Cleared Vial2Bag Advanced 13mm Admixture Device Read More

Aclaris Therapeutics

Aclaris Therapeutics and Sun Pharma Sign Exclusive Patent License Agreement for Alopecia Treatment

WAYNE, PA — Aclaris Therapeutics, Inc., a Pennsylvania-based biopharmaceutical company, announced this week that it has entered into an exclusive patent license agreement with Sun Pharmaceutical Industries, Inc. (Sun Pharma). …

Aclaris Therapeutics and Sun Pharma Sign Exclusive Patent License Agreement for Alopecia Treatment Read More
Annovis Bio

Annovis Bio Finalizes Phase III Study of Buntanetap in Early Parkinson’s Treatment, Awaits Topline Data

BERWYN, PA — Annovis Bio, Inc. (NYSE: ANVS) has recently announced the completion of the last patient visit in its phase III study of buntanetap, a leading candidate for treating …

Annovis Bio Finalizes Phase III Study of Buntanetap in Early Parkinson’s Treatment, Awaits Topline Data Read More
Teleflex Incorporated

Teleflex Scores Peripheral Access Purchasing Agreement with Premier, Inc., Expanding Reach of Innovative Vascular Products

WAYNE, PA — Teleflex Incorporated (NYSE: TFX), a global provider of medical technologies, recently announced a new Peripheral Access purchasing agreement with Premier, Inc. This agreement, effective from December 1, …

Teleflex Scores Peripheral Access Purchasing Agreement with Premier, Inc., Expanding Reach of Innovative Vascular Products Read More